Effective Cannabis

in 2016, Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes BACKGROUND: The commonality in symptomatology in these conditions displaying hyperalgesia and central sensitization with possible common underlying pathophysiology suggests that a clinical endocannabinoid deficiency might characterize their origin. You can read the full article here .. Read More

http://online.liebertpub.com/doi/abs/10.1089/can.2016.0009

In 2017, Mini Review of The Use of Cannabis for Headache Disorders BACKGROUND: This review considers historical prescription practices, summarizes the existing reports on the use of cannabis for headache, and examines the preclinical literature exploring the role of exogenous and endogenous cannabinoids to alter headache pathophysiology. You can read the full article here => http://online.liebertpub.com/doi/pdfplus/10.1089/can.2016.0033